ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASBP vs LSTA // OPERATING MARGIN

Aspire-Lakewood Holdings Inc. (NASDAQ) VS. Lisata Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ASBP 2 — LSTA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASBP VS. LSTA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASBP LSTA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -1.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) — -65.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 LSTA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.7 39.1 +6.60 ASBP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $11.4M $11.0M $354.6K ASBP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASBP REV LSTA REV ASBP GROSS % LSTA GROSS % ASBP FCF LSTA FCF
FY 2025 $6.2K $170.0K -1.9% — -$4.9M -$16.0M
FY 2024 $3.4M $1.0M — — -$265.2K -$19.4M
FY 2023 $20.1M $72.0M — — -$653.1K -$20.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASBP // BETA —
LSTA // BETA —